ORAGENICS, INC. Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net
ORAGENICS, INC. (OGEN) had Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net of $13.57 thousand as of 2016-06-30, per its 10-Q filed 2016-08-15.
Discontinued › Balance Sheet › Assets › Assets, Current › Disposal Group, Including Discontinued Operation, Assets, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet · last filed 2016-11-14
- 2016-06-30: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $13.57K.
- 2015-12-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $21.11K.
| Period end | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net |
|---|---|
| 2016-06-30 | $13.57K 10-Q · filed 2016-08-15 |
| 2015-12-31 | $21.11K 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |